Evidence map›Paper›PMID 32596293›Full record

SynthesisBioMed research international2020

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.

Zhu Tong, Lianrui Guo, Lixing Qi, Shijun Cui, Xixiang Gao, Yang Li, Jianming Guo, Yongquan Gu

Open access · hybridAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhu TongDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Lianrui GuoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Lixing QiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Shijun CuiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Xixiang GaoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Yang LiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Jianming GuoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Yongquan GuDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-8101-0539
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this article was to compare the efficiency and safety of drug-coated balloon angioplasty (DCB) and atherectomy with percutaneous transluminal angioplasty (PTA) in patients with femoropopliteal in-stent restenosis (ISR). Pubmed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) (all up to March 2019) were searched systematically. Trial sequential analysis (TSA) was conducted. 5 studies with 599 participants were included. Compared with PTA, DCB significantly increased the rate of patency (6 months: RR 1.65, 95% CI 1.30 to 2.09,

Indexed as

Angioplasty, BalloonAtherectomyCytoreduction Surgical ProceduresFemoral ArteryAgedAged, 80 and overCoated Materials, BiocompatibleFemaleHumansMaleMiddle AgedPeripheral Arterial DiseasePopliteal ArteryRecurrenceReoperationStentsCoated Materials, Biocompatible

Identifiers

PMID32596293
PMCPMC7303732
OpenAlexW3034663620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.